Menu Back toComplimentary - Optimize Your RWE Investments through a Platform Based Approach

Complimentary - Optimize Your RWE Investments through a Platform Based Approach


This Solution Provider Webinar is brought to you by DIA in cooperation with CitiusTech

With the increasing drug development cost, shift from volume to value-based pricing and competition from generics and biosimilars, pharma and life science organizations are looking towards real world evidence (RWE) to prove the value – cost, safety, and effectiveness of their medicinal products. However, the current real-world data comes in structured and unstructured format, in various data standards, and is laden with varied data quality issues. The industry is looking to define a platform-based approach to address the functional and technical complexities of RWE and harness the real-world datasets across the pharma value chain.
Join us for an intriguing presentation on “Optimize Your RWE Investments Through a Platform-Based Approach”, led by leading experts with multiple years of experience in CRO and technology industry.

Featured topics

  • Real World Evidence Dynamics, Challenges, and Considerations
  • Technological Approach for Effectively Leveraging RWE
  • Who should attend?

  • RWE
  • HEOR
  • Late Stage
  • Epidemiology in Pharma
  • CRO organizations
  • Learning objectives

  • Understand the key business use cases and stakeholders of RWE
  • Gather an industry perspective on RWE and its impact on entire pharma value chain
  • Current challenges and the need for a platform based approach
  • Understand the current state of RWE analytics implementation and associated complexity
  • Understand RWE business problem with respect to observational research
  • Get an overview of a platform-based approach to harness real-world datasets for observation research
  • Contact us

    Registration Questions?

    Send Email